Ignite Creation Date:
2024-05-06 @ 2:00 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01949870
Status:
TERMINATED
Last Update Posted:
2016-05-13
First Post:
2013-09-10
Brief Title:
Selumetinib AZD6244 ARRY-142886 J-BTC Phase 1 Study
Sponsor:
Organization:
AstraZeneca